copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Regulus Therapeutics Enters into Agreement to be Acquired by Novartis . . . Novartis to acquire Regulus for $7 00 per share in cash, with potential to receive an additional $7 00 per share in cash through a contingent value right, for a total equity value of up to approximately $1 7 billion Transaction is expected to be completed in the second half of 2025, subject to customary closing conditions SAN DIEGO, April 30, 2025 PRNewswire -- Regulus Therapeutics Inc
Regulus Therapeutics Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates April 30, 2025 Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG April 2, 2025 Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit